García-Posada: Clinical outcomes of patients hospitalized for COVID-19 and evidence-based on the pharmacological management reduce mortality in a region of the Colombian Caribbean

García-Posada, 209 patient colchicine late treatment study: 57% lower mortality [p=0.01] https://c19p.org/garciaposada

copied to clipboard

Clinical outcomes of patients hospitalized for COVID-19 and evidence-based on the pharmacological management reduce mortality in a region of the Colombian Caribbean

García-Posada et al., Journal of Infection and Public Health, doi:10.1016/j.jiph.2021.02.013

6 Mar 2021 Source PDF Share Tweet

Retrospective 209 hospitalized patients in Colombia, showing lower mortality with antibiotics + LMWH + corticosteroids + colchicine in multivariable analysis.

Important missing comments or errors? Let us know.

risk of death, 56.9% lower, RR 0.43, p = 0.01, treatment 48 of 99 (48.5%), control 59 of 110 (53.6%), adjusted per study, odds ratio converted to relative risk, multivariable.

Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates

García-Posada et al., 6 Mar 2021, retrospective, Colombia, peer-reviewed, 8 authors, this trial uses multiple treatments in the treatment arm (combined with antibiotics, LMWH, and corticosteroidsPERIOD:5/20-8/20) - results of individual treatments may vary.

All Studies Meta Analysis Submit Updates or Corrections

This Paper Colchicine All

Late treatment
is less effective

Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit